In Malta, all types of insulin, except for ultra-rapid acting analogs, are available free of charge for all people living with diabetes (PwD). While syringes, needles, insulin pens, blood glucose meters and test strips are also available free of charge for all PwD, real-time continuous glucose monitors are only reimbursed for people living with Type 1 Diabetes under the age of 40. Other technologies such as connected smart pens, insulin pumps, automated delivery systems and intermittently-scanned CGMs are not available in the country.

Malta is currently revising its national diabetes plan. Healthy living policies are in place and those targeting physical activity and smoking are integrated in the national non-communicable diseases strategy. Screening for all diabetes-related complications is available and people with gestational diabetes are followed up with an oral glucose tolerance test six weeks after the birth of the baby.

This country profile was developed with the help of the Maltese Diabetes Association.